Aspirin and omega-3 reduce pre-cancerous bowel polyps
- Details
- Category: Research
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research. A clinical trial, led by the University of Leeds, found that both aspirin and EPA reduced the number of bowel polyps in patients one year on from a screening colonoscopy (large bowel camera test), although they did not reduce the chances of an individual having any polyps present in the bowel.
Scorpion venom to shuttle drugs into the brain
- Details
- Category: Research
The Peptides and Proteins lab at the Institute for Research in Biomedicine (IRB Barcelona) has published a paper in Chemical Communications describing the capacity of a small molecule (peptide) derived from chlorotoxin, found in scorpion venom (Giant Yellow Israeli scorpion), to carry drugs across the blood-brain barrier (BBB).
Patient engagement as a new blockbuster drug, not quite yet, study finds
- Details
- Category: Research
If patient engagement is the new 'blockbuster drug,' why are we not seeing spectacular effects? A team of researchers from The Dartmouth Institute for Health Policy and Clinical Practice and the Berkeley School of Public Health at UC Berkeley recently conducted a study designed to help answer that question and to better understand how patient engagement and activation (PAE) practices
Obesity both feeds tumors and helps immunotherapy kill cancer
- Details
- Category: Research
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give cancer doctors important new information when choosing drugs and other treatments for cancer patients.
Blue light can reduce blood pressure
- Details
- Category: Research
Exposure to blue light decreases blood pressure, reducing the risk of developing cardiovascular disease, a new study from the University of Surrey and Heinrich Heine University Dusseldorf in collaboration with Philips reports. During this study, published in the prestigious European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometres, a dose comparable to daily sunlight - followed by exposure to a control light on a different day.
Gap in research means millions living with long-term consequences of cancer
- Details
- Category: Research
Millions of people are living with the long-term consequences of cancer and its treatment, but currently there is very little research on the problems they face and how these can be tackled, according to the UK's National Cancer Research Institute (NCRI). Thanks to successes in research on diagnosing and treating cancer, more people are living longer with cancer and with the lasting side-effects of treatments.
Tumour immune cells could aid cancer therapies
- Details
- Category: Research
A pioneering technique designed to spot differences between immune cells in tumours could speed the development of cancer treatments, research suggests. Scientists say the approach could be used to help doctors choose the best treatments for individual patients and predict which tumours are likely to respond to a particular therapy.
More Pharma News ...
- Can chocolate, tea, coffee and zinc help make you more healthy?
- Twenty years on, measuring the impact of human stem cells
- Breakthrough neurotechnology for treating paralysis
- Economic impact of excess weight now exceeds $1.7 trillion
- World Stroke Day - SVIN latest clinical trials and breaking science news
- New epigenetic drug strategy to treat cancer
- Largest census of cancer genes to help understand drug targets